BANNER OCOTILLO MEDICAL CENTER
1. Target Overview & Investment Thesis
BANNER OCOTILLO MEDICAL CENTER is a 94-bed safety-net/medicaid heavy in MARICOPA, AZ with $88.1M in net patient revenue and a -17.9% operating margin. The hospital serves a payer mix of 20.5% Medicare, 24.6% Medicaid, and 54.9% commercial.
Thesis: Turnaround. Our ML models identify $6.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.9% to -10.6% (+736bps).
| Net Revenue HCRIS | $88.1M |
| Current EBITDA COMPUTED | $-15.8M |
| Operating Margin COMPUTED | -17.9% |
| Occupancy HCRIS | 50.0% |
| Revenue / Bed COMPUTED | $937K |
| Net-to-Gross HCRIS | 21.2% |
| Distress Probability ML | 52.3% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -17.9% places it below the state median. Among 56 size-comparable peers (47-188 beds), the median margin is 1.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (47-188), prioritizing same-state peers. 56 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BANNER OCOTILLO MEDICAL CENTER (Target) | AZ | 94 | $88.1M | -17.9% |
| BANNER GATEWAY MEDICAL CENTER | AZ | 185 | $573.8M | 5.2% |
| HAVASU REGIONAL MEDICAL CENTER | AZ | 144 | $256.1M | 16.9% |
| SUMMIT HEALTHCARE | AZ | 89 | $254.1M | -2.9% |
| MOUNTAIN VISTA MEDICAL CENTER | AZ | 162 | $223.9M | -1.0% |
| BANNER UNIVERSITY MED CENTER S | AZ | 132 | $190.9M | -16.3% |
| HONORHEALTH SCOTTSDALE THOMPSO | AZ | 120 | $187.9M | -1.6% |
| VERDE VALLEY MEDICAL CENTER | AZ | 87 | $172.5M | 4.3% |
| BANNER HEART HOSPITAL | AZ | 108 | $162.2M | 17.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $56K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-15.8M |
| + RCM Uplift | +$6.5M |
| Pro Forma EBITDA | $-9.3M |
| Current Margin | -17.9% |
| Pro Forma Margin | -10.6% |
| WC Released (1x) | $3.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-24.3M | $-39.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-24.3M | $-51.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-21.9M | $-37.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-21.9M | $-47.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-26.8M | $-64.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-26.8M | $-79.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (24.6%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 52.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 56 hospitals with 47-188 beds
- Same-state prioritization (n=57)
- Comp margins: P25=-10.7% / P50=1.9% / P75=8.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.